{"id":223744,"date":"2017-06-27T15:46:35","date_gmt":"2017-06-27T19:46:35","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/mission-health-takes-national-leadership-role-in-personalized-medicine-mountain-xpress-blog.php"},"modified":"2017-06-27T15:46:35","modified_gmt":"2017-06-27T19:46:35","slug":"mission-health-takes-national-leadership-role-in-personalized-medicine-mountain-xpress-blog","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/genetic-medicine\/mission-health-takes-national-leadership-role-in-personalized-medicine-mountain-xpress-blog.php","title":{"rendered":"Mission Health Takes National Leadership Role in Personalized Medicine &#8211; Mountain Xpress (blog)"},"content":{"rendered":"<p><p>From Mission Health:        <\/p>\n<p>      Mission Healths Personalized Medicine program focuses on      response to drugs in a way that will increase the likelihood      that a drug will work effectively while decreasing the      likelihood that it will result in a bad side effect for our      patients. Personalized medicine testing utilizes the genetic      make-up of the individual, or in cancer, the genetic makeup      of the patients tumor to predict which drug might be the      best match for an individual patient. Mission Health is one      of the few community health systems in the nation to offer      this vital program for both cancer patients and non-cancer      patients.    <\/p>\n<p>      Important initiatives that are fueling the study and practice      of personalized medicine at Mission Health are the 2013      recruitment of nationally known personalized medicine expert      Lynn Dressler, PhD to develop and direct the      Mission Personalized Medicine Program, the opening of      Missions Personalized Medicine Clinic in the Fullerton      Genetics Center and a grant from the North Carolina      Biotechnology Center (NCBC) to help bring this testing to      primary care providers in western North Carolina (the grant      helps cover the cost of testing). The NCBC is a private      nonprofit organization devoted to building long-term societal      and economic benefits to North Carolina by supporting      biotechnology research, business, and education across the      state.    <\/p>\n<p>      The NCBC funded pilot study focuses on how testing for drug      response can be used effectively in a primary care setting.      The pilot study evaluates the barriers that might prevent      primary care practices from adopting this testing and how      those barriers could be addressed, including opportunities      for economic development and job growth. The Mission      Personalized Medicine team provides education and training      for providers to use and interpret test results.    <\/p>\n<p>      Dr. Dresslers interest in pursuing solutions to obstacles      that currently exist for primary care practices to adopt      personalized medicine testing for drug response is the      opportunity to enhance care and reduce costs with minimal      disruption to the primary care practice current work flow.      Patients can only benefit if their providers adopt testing,      says Dressler. This study will provide free testing and free      education and training to providers, so at least those main      barriers are off the table. By giving clinicians and      patients an opportunity to try out this testing within a      safe environment, it may identify and address other barriers      that we have not yet realized.    <\/p>\n<p>      One year into the NCBC funded study, Dressler and the PM team      has successfully recruited 10 clinicians from four primary      care practices and tested 41 patients. Recommendations for      changes in medication management were suggested in more than      one third of patients. The study has already identified      additional barriers to be addressed to make this testing more      efficient and available to more patients and providers.      Future plans for the study include recruitment of several      additional practices, with a goal of recruiting approximately      80 total patients from the region. Mission Health plans      to conduct other pilot studies to enhance drug management in      areas such as behavioral health and supportive care for      cancer patients.    <\/p>\n<p>      Ronald A. Paulus, M.D., President and CEO of      Mission Health, who will be speaking at the 13th Annual      Personalized Medicine Conference at Harvard Medical School in      November declares that personalized medicine offers      extraordinary medical possibilities. If we can harness the      power of this transformational biomedical technology      successfully  and we are already beginning to  we can      improve outcomes for our patients and increase the      effectiveness of our dedicated clinicians skillful and      compassionate care. At the same time, this technology      empowers our patients to be informed, shared decision-makers      with their physicians. It is truly an exciting time,      he says.    <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>View post: <\/p>\n<p><a target=\"_blank\" href=\"https:\/\/mountainx.com\/blogwire\/mission-health-takes-national-leadership-role-in-personalized-medicine\/\" title=\"Mission Health Takes National Leadership Role in Personalized Medicine - Mountain Xpress (blog)\">Mission Health Takes National Leadership Role in Personalized Medicine - Mountain Xpress (blog)<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> From Mission Health: Mission Healths Personalized Medicine program focuses on response to drugs in a way that will increase the likelihood that a drug will work effectively while decreasing the likelihood that it will result in a bad side effect for our patients. Personalized medicine testing utilizes the genetic make-up of the individual, or in cancer, the genetic makeup of the patients tumor to predict which drug might be the best match for an individual patient.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/genetic-medicine\/mission-health-takes-national-leadership-role-in-personalized-medicine-mountain-xpress-blog.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[5],"tags":[],"class_list":["post-223744","post","type-post","status-publish","format-standard","hentry","category-genetic-medicine"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/223744"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=223744"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/223744\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=223744"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=223744"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=223744"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}